Analysis of nanoparticle-protein coronas formed in vitro between nanosized welding particles and nasal lavage proteins.
2016 (English)In: Nanotoxicology, ISSN 1743-5390, E-ISSN 1743-5404, Vol. 10, no 2, 226-234 p.Article in journal (Refereed) Published
Welding fumes include agglomerated particles built up of primary nanoparticles. Particles inhaled through the nose will to some extent be deposited in the protein-rich nasal mucosa, and a protein corona will be formed around the particles. The aim was to identify the protein corona formed between nasal lavage proteins and four types of particles with different parameters. Two of the particles were formed and collected during welding and two were manufactured iron oxides. When nasal lavage proteins were added to the particles, differences were observed in the sizes of the aggregates that were formed. Measurements showed that the amount of protein bound to particles correlated with the relative size increase of the aggregates, suggesting that the surface area was associated with the binding capacity. However, differences in aggregate sizes were detected when nasal proteins were added to UFWF and Fe2O3 particles (having similar agglomerated size) suggesting that yet parameters other than size determine the binding. Relative quantitative mass spectrometric and gel-based analyses showed differences in the protein content of the coronas. High-affinity proteins were further assessed for network interactions. Additional experiments showed that the inhibitory function of secretory leukocyte peptidase inhibitor, a highly abundant nasal protein, was influenced by particle binding suggesting that an understanding of protein function following particle binding is necessary to properly evaluate pathophysiological events. Our results underscore the importance of including particles collected from real working environments when studying the toxic effects of particles because these effects might be mediated by the protein corona.
Place, publisher, year, edition, pages
Taylor & Francis, 2016. Vol. 10, no 2, 226-234 p.
Respiratory Medicine and Allergy
IdentifiersURN: urn:nbn:se:liu:diva-122249DOI: 10.3109/17435390.2015.1048324ISI: 000371822800010PubMedID: 26186033OAI: oai:DiVA.org:liu-122249DiVA: diva2:864182
Funding agencies: AFA Insurance and Forte; medical faculty of Lund University; Nanometer Structure Consortium (nmC) at Lund University2015-10-262015-10-262016-05-04